Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 7Cohance Lifesciences
02 13Granules India Limited
03 32care4
04 7Actavis Inc
05 13Ajanta Pharma Limited
06 7Alkem Laboratories
07 7Alvogen
08 6Amneal Pharmaceuticals
09 14Apotex Inc
10 9Assia Chemical Industries Ltd
11 7Elite Laboratories
12 1FrostPharma AB
13 7Hikma Pharmaceuticals
14 7Lannett Company, Inc.
15 6MSN Laboratories
16 13Mallinckrodt Pharmaceuticals
17 1Medartuum AB
18 2ORIFARM GROUP AS
19 7PRO DOC LIMITEE
20 7Prinston
21 7RHODES PHARMACEUTICALS LP
22 15SHIRE PLC
23 23Sandoz B2B
24 13Sun Pharmaceutical Industries Limited
25 47Takeda Pharmaceutical
26 6Takeda Pharmaceuticals Australia Pty. Ltd.
27 6Taro Pharmaceutical Industries
28 13Teva Pharmaceutical Industries
29 7Viatris
01 3CAP
02 35CAPSULE
03 118CAPSULE;ORAL
04 6Caps
05 7Capsule
06 6Capsule, hard
07 10HARD CAPSULES
08 35Kapsel, hard
09 1Mixture, solution
10 12TABLET (CHEWABLE)
11 42TABLET, CHEWABLE;ORAL
12 3capsule
13 3Blank
01 3Originator
02 160RX
03 47Schedule G (CDSA I)
04 71Blank
01 7APO-LISDEXAMFETAMINE CAPSULES
02 3Adult lisdexamfetamine
03 11Aduvanz
04 6Balidax
05 6Dexhility
06 18Elvanse
07 147LISDEXAMFETAMINE DIMESYLATE
08 1Lisarol
09 3Oferlanz
10 7PRO-LISDEXAMFETAMINE
11 7SANDOZ LISDEXAMFETAMINE CAPSULES
12 6TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
13 7TEVA-LISDEXAMFETAMINE
14 26VYVANSE
15 3Volidax
16 6Vyvanse
17 1Vyvanse 30
18 1Vyvanse 50
19 1Vyvanse 70
20 7lisdexamfetamine
21 7Blank
01 6Australia
02 47Canada
03 7India
04 42Norway
05 3South Africa
06 10Sweden
07 6Switzerland
08 160USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2025-01-29
Application Number : 218987
Regulatory Info : RX
Registration Country : USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 70MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2025-01-29
Application Number : 218987
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2025-01-29
Application Number : 218987
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2025-01-29
Application Number : 218987
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2025-01-29
Application Number : 218987
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 60MG
Packaging :
Approval Date : 2025-01-29
Application Number : 218987
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 70MG
Packaging :
Approval Date : 2025-01-29
Application Number : 218987
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : TABLET, CHEWABLE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2024-12-16
Application Number : 219258
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : TABLET, CHEWABLE;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2024-12-16
Application Number : 219258
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : TABLET, CHEWABLE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2024-12-16
Application Number : 219258
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : TABLET, CHEWABLE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2024-12-16
Application Number : 219258
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : TABLET, CHEWABLE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2024-12-16
Application Number : 219258
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : TABLET, CHEWABLE;ORAL
Dosage Strength : 60MG
Packaging :
Approval Date : 2024-12-16
Application Number : 219258
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : SANDOZ LISDEXAMFETAMINE CAPSULES
Dosage Form : CAPSULE
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 2546280
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : SANDOZ LISDEXAMFETAMINE CAPSULES
Dosage Form : CAPSULE
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number : 2546299
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : SANDOZ LISDEXAMFETAMINE CAPSULES
Dosage Form : CAPSULE
Dosage Strength : 70MG
Packaging :
Approval Date :
Application Number : 2546302
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2007-02-23
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2007-02-23
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 70MG
Packaging :
Approval Date : 2007-02-23
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2007-12-10
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2007-12-10
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : TEVA-LISDEXAMFETAMINE
Dosage Form : CAPSULE
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number : 2545888
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : TEVA-LISDEXAMFETAMINE
Dosage Form : CAPSULE
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number : 2545896
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
